Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects.

    Roest PA, Molin DG, Schalkwijk CG, van Iperen L, Wentzel P, Eriksson UJ, Gittenberger-de Groot AC.

    Diabetes. 2009 May;58(5):1222-8. Epub 2009 Feb 2.PMID: 19188426 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteine.

    Roest PA, van Iperen L, Vis S, Wisse LJ, Poelmann RE, Steegers-Theunissen RP, Molin DG, Eriksson UJ, Gittenberger-De Groot AC.

    Birth Defects Res A Clin Mol Teratol. 2007 Mar;79(3):231-5.PMID: 17183584 [PubMed - indexed for MEDLINE]Related articles

    3.

    Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats.

    Molin DG, Roest PA, Nordstrand H, Wisse LJ, Poelmann RE, Eriksson UJ, Gittenberger-De Groot AC.

    Birth Defects Res A Clin Mol Teratol. 2004 Dec;70(12):927-38.PMID: 15578651 [PubMed - indexed for MEDLINE]Related articles

    4.

    New possibilities for prenatal diagnosis of muscular dystrophies: forced myogenesis with an adenoviral MyoD-vector.

    Roest PA, Bakker E, Fallaux FJ, Verellen-Dumoulin C, Murry CE, den Dunnen JT.

    Lancet. 1999 Feb 27;353(9154):727-8. No abstract available. PMID: 10073525 [PubMed - indexed for MEDLINE]Related articles

    5.

    Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD.

    Roest PA, Bout M, van der Tuijn AC, Ginjaar IB, Bakker E, Hogervorst FB, van Ommen GJ, den Dunnen JT.

    J Med Genet. 1996 Nov;33(11):935-9.PMID: 8950674 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins.

    Roest PA, van der Tuijn AC, Ginjaar HB, Hoeben RC, Hoger-Vorst FB, Bakker E, den Dunnen JT, van Ommen GJ.

    Neuromuscul Disord. 1996 May;6(3):195-202.PMID: 8784808 [PubMed - indexed for MEDLINE]Related articles

    7.

    Protein truncation test (PTT) for rapid detection of translation-terminating mutations.

    Roest PA, Roberts RG, Sugino S, van Ommen GJ, den Dunnen JT.

    Hum Mol Genet. 1993 Oct;2(10):1719-21.PMID: 8268929 [PubMed - indexed for MEDLINE]Related articles

    8.

    Protein truncation test (PTT) to rapidly screen the DMD gene for translation terminating mutations.

    Roest PA, Roberts RG, van der Tuijn AC, Heikoop JC, van Ommen GJ, den Dunnen JT.

    Neuromuscul Disord. 1993 Sep-Nov;3(5-6):391-4.PMID: 8186681 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.

    Maas RA, Roest PA, Becker MJ, Weimar IS, Dullens HF, Den Otter W.

    Immunobiology. 1992 Nov;186(3-4):214-29.PMID: 1490728 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...